Abstract
Presymptomatic and predictive genetic testing should involve a considered choice, which is particularly true when testing is undertaken in early adulthood. Young adults are at a key life stage as they may be developing a career, forming partnerships and potentially becoming parents: presymptomatic testing may affect many facets of their future lives. The aim of this integrative systematic review was to assess factors that influence young adults’ or adolescents’ choices to have a presymptomatic genetic test and the emotional impact of those choices. Peer-reviewed papers published between January 1993 and December 2014 were searched using eight databases. Of 3373 studies identified, 29 were reviewed in full text: 11 met the inclusion criteria. Thematic analysis was used to identify five major themes: period befeore testing, experience of genetic counselling, parental involvement in decision-making, impact of test result communication, and living with genetic risk. Many participants grew up with little or no information concerning their genetic risk. The experience of genetic counselling was either reported as an opportunity for discussing problems or associated with feelings of disempowerment. Emotional outcomes of disclosure did not directly correlate with test results: some mutation carriers were relieved to know their status, however, the knowledge they may have passed on the mutation to their children was a common concern. Parents appeared to have exerted pressure on their children during the decision-making process about testing and risk reduction surgery. Health professionals should take into account all these issues to effectively assist young adults in making decisions about presymptomatic genetic testing.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Evans JP, Skrzynia C, Burke W : The complexities of predictive genetic testing. BMJ 2001; 322: 1052–1056.
MacLeod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L : Experiences of predictive testing in young people at risk of Huntington/’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer. Eur J Hum Genet 2013; 22: 396–401.
Borry P, Goffin T, Nys H, Dierickx K : Predictive genetic testing in minors for adult-onset genetic diseases. Mt Sinai J Med 2008; 75: 287–296.
Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K : Genetic testing in asymptomatic minors: background considerations towards ESHG recommendations. Eur J Hum Genet 2009; 17: 711–719.
Clarke A : The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet 1994; 31: 785.
CRD Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care. Centre for Reviews and Dissemination: University of York, York, UK, 2009.
Harper PS : A specific mutation for Huntington’s disease. J Med Genet 1993; 30: 975–977.
PRISMA Statement website http://www.prisma-statement.org/ (accessed 28 October 2014).
Kmet LM, Lee RC : Standard quality assessment criteria for evaluating primary research papers from avariety of fields. HTA Initiat 2004; 13: 1–28.
Braun V, Clarke V : Using thematic analysis in psychology. Qual Res Psychol 2008; 3: 77–101.
MacLeod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L : Experiences of predictive testing in young people at risk of Huntington’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer. Eur J Hum Genet EJHG 2014; 22: 396–401.
Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatyckil MB : “Holding your breath”: Interviews with young people who have undergone predictive genetic testing for Huntington disease. Am J Med Genet Part A 2007; 143A: 1984–1989.
Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB : The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer 2010; 9: 27–35.
Macrae L, de Souza AN, Loiselle CG, Wong N : Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study. Hered Cancer Clin Pract 2013; 11: 14.
Mand C, Gillam L, Duncan RE, Delatycki MB : “It was the missing piece”: adolescent experiences of predictive genetic testing for adult-onset conditions. Genet Med 2013; 15: 643–649.
Patenaude AF, Tung N, Ryan PD, Ellisen LW, Hewitt L, Schneider KA et al: Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry? Psychooncology 2013; 22: 2024–2031.
Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB : “You’re one of us now”: young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet 2008; 148c: 47–55.
Hamilton R, Williams JK, Bowers BJ, Calzone K : Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. J Genet Couns 2009; 18: 147–159.
Hamilton R : Being young, female, and BRCA positive. Am J Nurs 2012; 112: 26.
Werner-Lin A, Hoskins LM, Doyle MH, Greene MH : “Cancer doesn't have an age” genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24. Heal (London, Engl 1997) 2012; 16: 636–654.
Hoskins LM, Werner-Lin A, Greene MH : In their own words: treating very young BRCA1/2 mutation-positive women with care and caution. PLoS One 2014; 9: e87696.
Rew L, Mackert M, Bonevac D : A systematic review of literature about the genetic testing of adolescents. J Spec Pediatr Nurs 2009; 14: 284–294.
Sobel SK, Cowan DB : Impact of genetic testing for Huntington disease on the family system. Am J Med Genet 2000; 90: 49–59.
Sobel S, Cowan CB : Ambiguous loss and disenfranchised grief: the impact of DNA predictive testing on the family as a system. Fam Process 2003; 42: 47–57.
Metcalfe A, Coad J, Plumridge GM, Gill P, Farndon P : Family communication between children and their parents about inherited genetic conditions: a meta-synthesis of the research. Eur J Hum Genet 2008; 16: 1193–1200.
Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA et al: How often do BRCA mutation carriers tell their young children of the family’s risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol 2007; 25: 3705–3711.
Werner-Lin A, Ratner R, Hoskins LM, Lieber C : A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome. J Genet Couns 2015; 24: 78–87.
Gaff CL, Lynch E, Spencer L : Predictive testing of eighteen year olds: counseling challenges. J Genet Couns 2006; 15: 245–251.
Broadstock M, Michie S, Marteau T : Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000; 8: 731–738.
Borry P, Stultiens L, Nys H, Cassiman J-J, Dierickx K : Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 2006; 70: 374–381.
Richards FH : Predictive genetic testing of adolescents for Huntington disease: a question of autonomy and harm. Am J Med Genet Part A 2008; 146A: 2443–2446.
Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB : Reply to Richards: “Predictive genetic testing of adolescents for Huntington disease: a question of autonomy and harm.”. Am J Med Genet Part A 2008; 146A: 2447–2448.
Department of Health Reference Guide to Consent for Examination or Treatment, 2nd edn 2009 London: Department of Health.
Steinberg L, Cauffman E : Maturity of judgment in adolescence: psychosocial factors in adolescent decision making. Law Hum Behav 1996; 20: 249–272.
Richards FH : Maturity of judgement in decision making for predictive testing for nontreatable adult-onset neurogenetic conditions: a case against predictive testing of minors. Clin Genet 2006; 70: 396–401.
Acknowledgements
LG is supported by the Grant from Regione Emilia-Romagna ‘Diagnostics advances in hereditary breast cancer (DIANE)’ (PRUa1GR-2012-001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Godino, L., Turchetti, D., Jackson, L. et al. Impact of presymptomatic genetic testing on young adults: a systematic review. Eur J Hum Genet 24, 496–503 (2016). https://doi.org/10.1038/ejhg.2015.153
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2015.153
This article is cited by
-
Ordering genetic testing by neurologists: points to consider
Journal of Neurology (2023)
-
Outcomes of support groups for carriers of BRCA 1/2 pathogenic variants and their relatives: a systematic review
European Journal of Human Genetics (2022)
-
Minors at risk of von Hippel-Lindau disease: 10 years’ experience of predictive genetic testing and follow-up adherence
European Journal of Human Genetics (2022)
-
Perceptions of genetic testing in patients with hereditary chronic pancreatitis and their families: a qualitative triangulation
European Journal of Human Genetics (2021)
-
Genetic counselling as a route to enhanced autonomy: using a sequential mixed methods research approach to develop a theory regarding presymptomatic genetic testing for young adults at risk of inherited cancer syndromes
Journal of Community Genetics (2021)
